Top Markets
Coin of the day
Elevation Oncology, Inc. Elevation Oncology, Inc.

Elevation Oncology, Inc.

ELEV
Classement en actions #29361
Elevation Oncology, Inc. is a clinical-stage biopharmaceutical company... Elevation Oncology, Inc. is a clinical-stage biopharmaceutical company operating in the United States, committed to developing targeted cancer therapies for patients with specific genetic profiles. Its leading drug candidate is seribantumab, an anti-HER3 monoclonal antibody currently being evaluated in the Phase II CRESTONE trial. This study focuses on treating advanced solid tumors that harbor a neuregulin-1 fusion. The company was established in 2019 and is headquartered in New York, New York.
Prix de l'action
$0.365
Dernière synchronisation: 2025-08-01
Capitalisation boursière
$21.54M
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
US
Échange Elevation Oncology, Inc. (ELEV)

Catégorie

Le prix ELEV avec la capitalisation boursière de B
Elevation Oncology, Inc. Elevation Oncology, Inc.
ELEV
$0.365
Capitalisation boursière de Elevation Oncology, Inc.(ELEV)
Capitalisation boursière: $21.54M
En August 2026, Elevation Oncology, Inc. a une capitalisation boursière de $21.54M. Cela fait de Elevation Oncology, Inc. la 29361st entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Elevation Oncology, Inc. du 2021 au 2026
ELEV par rapport au top 5 des plus populaires stocks
Prix pour ELEV L’actif B La capitalisation boursière de B Résultats
Elevation Oncology, Inc. Elevation Oncology, Inc.
$90,338.83 $21.54M
$5.332T +24,750,264.06%
Elevation Oncology, Inc. Elevation Oncology, Inc.
$77,298.68 $21.54M
$4.562T +21,177,619.30%
Elevation Oncology, Inc. Elevation Oncology, Inc.
$70,177.18 $21.54M
$4.142T +19,226,525.54%
Elevation Oncology, Inc. Elevation Oncology, Inc.
$60,678.09 $21.54M
$3.581T +16,624,033.84%
Elevation Oncology, Inc. Elevation Oncology, Inc.
$47,258.21 $21.54M
$2.789T +12,947,353.94%